MBNL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62592161956354E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.12430114901963E-13 |
Normal-vs-Stage2 |
4.209900E-04 |
Normal-vs-Stage3 |
1.96810012731419E-10 |
Normal-vs-Stage4 |
2.09970041353813E-10 |
Stage1-vs-Stage2 |
4.542000E-01 |
Stage1-vs-Stage3 |
4.108600E-01 |
Stage1-vs-Stage4 |
7.260400E-01 |
Stage2-vs-Stage3 |
7.285600E-01 |
Stage2-vs-Stage4 |
5.652200E-01 |
Stage3-vs-Stage4 |
6.774600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.11022302462516E-16 |
Normal-vs-AfricanAmerican |
6.819900E-03 |
Normal-vs-Asian |
3.804200E-02 |
Caucasian-vs-AfricanAmerican |
7.041500E-03 |
Caucasian-vs-Asian |
7.845200E-01 |
AfricanAmerican-vs-Asian |
1.307560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.84430248850731E-12 |
Normal-vs-Female |
7.97140131680862E-14 |
Male-vs-Female |
3.605800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.984100E-04 |
Normal-vs-Age(41-60Yrs) |
9.54791801177635E-15 |
Normal-vs-Age(61-80Yrs) |
5.3481663542243E-12 |
Normal-vs-Age(81-100Yrs) |
5.702700E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.222200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.556400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.257800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.787500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.197900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.053600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.85950000011859E-07 |
Normal-vs-Grade 2 |
2.77156075867424E-12 |
Normal-vs-Grade 3 |
8.25117751901416E-13 |
Normal-vs-Grade 4 |
5.23679999364646E-09 |
Grade 1-vs-Grade 2 |
4.830400E-01 |
Grade 1-vs-Grade 3 |
1.138050E-01 |
Grade 1-vs-Grade 4 |
2.212400E-01 |
Grade 2-vs-Grade 3 |
1.202430E-01 |
Grade 2-vs-Grade 4 |
3.450600E-01 |
Grade 3-vs-Grade 4 |
7.079000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62758695410048E-12 |
Normal-vs-ccB subtype |
1.59270374666676E-11 |
ccA subtype-vs-ccB subtype |
1.391370E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.7065463465733E-14 |
Normal-vs-N1 |
4.295400E-03 |
N0-vs-N1 |
8.726400E-01 |
|
|